Cargando…

Non-invasive score identifies ultrasonography-diagnosed non-alcoholic fatty liver disease and predicts mortality in the USA

BACKGROUND: Several non-invasive prediction scores for non-alcoholic fatty liver disease (NAFLD) have been developed, but their performance has not been compared and validated in the same population, and whether these prediction scores can predict clinical outcomes remains unknown. In this study, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheung, Ching-Lung, Lam, Karen SL, Wong, Ian CK, Cheung, Bernard MY
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207316/
https://www.ncbi.nlm.nih.gov/pubmed/25204761
http://dx.doi.org/10.1186/s12916-014-0154-x
_version_ 1782340948938719232
author Cheung, Ching-Lung
Lam, Karen SL
Wong, Ian CK
Cheung, Bernard MY
author_facet Cheung, Ching-Lung
Lam, Karen SL
Wong, Ian CK
Cheung, Bernard MY
author_sort Cheung, Ching-Lung
collection PubMed
description BACKGROUND: Several non-invasive prediction scores for non-alcoholic fatty liver disease (NAFLD) have been developed, but their performance has not been compared and validated in the same population, and whether these prediction scores can predict clinical outcomes remains unknown. In this study, we aimed to validate and compare the performance of four NAFLD prediction scores: fatty liver index, hepatic steatosis index, lipid accumulation product, and NAFLD liver fat score (LFS), and to evaluate the ability of the best NAFLD prediction score to predict mortality. METHODS: We analyzed data from the National Health and Nutrition Examination Survey conducted in 1988 to 1994, and subsequent follow-up data for mortality up to December 31, 2006. NAFLD was defined by ultrasonographic detection of hepatic steatosis in the absence of other known liver diseases. RESULTS: In a group of 5,184 participants, LFS consistently showed the highest area under the curve for predicting the presence of NAFLD. During a median follow-up of 14.7 years (range 0.1 to 18.2 years) and 83,830.5 person-years, participants in the high LFS group (LFS ≥1.257) had a higher cardiovascular and liver-related mortality than participants in the low (LFS ≤ −1.413; cardiovascular hazard ratio (HR) = 2.24, 95% CI 1.03 to 4.88; liver HR = 31.25, 95% CI 3.13 to 333.33) or intermediate (−1.413 < LFS < 1.257; cardiovascular HR = 2.3, 95% CI 1.19 to 4.48; liver HR = 30.3, 95% CI 4 to 250) LFS groups in the fully adjusted model. Similar results were obtained when LFS was treated as a continuous variable. CONCLUSIONS: LFS is the best non-invasive prediction score for NAFLD, and people with a high LFS score have an increased risk for cardiovascular and liver-related mortality. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12916-014-0154-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4207316
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42073162014-10-28 Non-invasive score identifies ultrasonography-diagnosed non-alcoholic fatty liver disease and predicts mortality in the USA Cheung, Ching-Lung Lam, Karen SL Wong, Ian CK Cheung, Bernard MY BMC Med Research Article BACKGROUND: Several non-invasive prediction scores for non-alcoholic fatty liver disease (NAFLD) have been developed, but their performance has not been compared and validated in the same population, and whether these prediction scores can predict clinical outcomes remains unknown. In this study, we aimed to validate and compare the performance of four NAFLD prediction scores: fatty liver index, hepatic steatosis index, lipid accumulation product, and NAFLD liver fat score (LFS), and to evaluate the ability of the best NAFLD prediction score to predict mortality. METHODS: We analyzed data from the National Health and Nutrition Examination Survey conducted in 1988 to 1994, and subsequent follow-up data for mortality up to December 31, 2006. NAFLD was defined by ultrasonographic detection of hepatic steatosis in the absence of other known liver diseases. RESULTS: In a group of 5,184 participants, LFS consistently showed the highest area under the curve for predicting the presence of NAFLD. During a median follow-up of 14.7 years (range 0.1 to 18.2 years) and 83,830.5 person-years, participants in the high LFS group (LFS ≥1.257) had a higher cardiovascular and liver-related mortality than participants in the low (LFS ≤ −1.413; cardiovascular hazard ratio (HR) = 2.24, 95% CI 1.03 to 4.88; liver HR = 31.25, 95% CI 3.13 to 333.33) or intermediate (−1.413 < LFS < 1.257; cardiovascular HR = 2.3, 95% CI 1.19 to 4.48; liver HR = 30.3, 95% CI 4 to 250) LFS groups in the fully adjusted model. Similar results were obtained when LFS was treated as a continuous variable. CONCLUSIONS: LFS is the best non-invasive prediction score for NAFLD, and people with a high LFS score have an increased risk for cardiovascular and liver-related mortality. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12916-014-0154-x) contains supplementary material, which is available to authorized users. BioMed Central 2014-09-10 /pmc/articles/PMC4207316/ /pubmed/25204761 http://dx.doi.org/10.1186/s12916-014-0154-x Text en © Cheung et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Cheung, Ching-Lung
Lam, Karen SL
Wong, Ian CK
Cheung, Bernard MY
Non-invasive score identifies ultrasonography-diagnosed non-alcoholic fatty liver disease and predicts mortality in the USA
title Non-invasive score identifies ultrasonography-diagnosed non-alcoholic fatty liver disease and predicts mortality in the USA
title_full Non-invasive score identifies ultrasonography-diagnosed non-alcoholic fatty liver disease and predicts mortality in the USA
title_fullStr Non-invasive score identifies ultrasonography-diagnosed non-alcoholic fatty liver disease and predicts mortality in the USA
title_full_unstemmed Non-invasive score identifies ultrasonography-diagnosed non-alcoholic fatty liver disease and predicts mortality in the USA
title_short Non-invasive score identifies ultrasonography-diagnosed non-alcoholic fatty liver disease and predicts mortality in the USA
title_sort non-invasive score identifies ultrasonography-diagnosed non-alcoholic fatty liver disease and predicts mortality in the usa
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207316/
https://www.ncbi.nlm.nih.gov/pubmed/25204761
http://dx.doi.org/10.1186/s12916-014-0154-x
work_keys_str_mv AT cheungchinglung noninvasivescoreidentifiesultrasonographydiagnosednonalcoholicfattyliverdiseaseandpredictsmortalityintheusa
AT lamkarensl noninvasivescoreidentifiesultrasonographydiagnosednonalcoholicfattyliverdiseaseandpredictsmortalityintheusa
AT wongianck noninvasivescoreidentifiesultrasonographydiagnosednonalcoholicfattyliverdiseaseandpredictsmortalityintheusa
AT cheungbernardmy noninvasivescoreidentifiesultrasonographydiagnosednonalcoholicfattyliverdiseaseandpredictsmortalityintheusa